# Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis

> **NCT03760198** · PHASE3 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 220 (actual)

## Conditions studied

- Hyperhidrosis Primary Focal Axilla

## Interventions

- **DRUG:** Meditoxin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03760198
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-03
- **Primary completion:** 2019-07-03
- **Final completion:** 2019-09-17
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2020-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03760198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03760198, "Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Primary Axillary Hyperhidrosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03760198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*